Harmonic, Inc (NASDAQ: HLIT)’s stock price has plunge by 0.87relation to previous closing price of 9.18. Nevertheless, the company has seen a -0.64% plunge in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-12 that Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third quarter of 2025 THB335 demonstrated 85% serum tryptase reduction with an encouraging safety profile in an additional Phase 1 cohort evaluating 100mg dose with new drug product capsule formulation Company initiating a sale process of THB335 SAN FRANCISCO, June 12, 2025 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc. (Nasdaq: THRD) today announced that its stockholders overwhelmingly approved the previously proposed Plan of Liquidation and Dissolution (the “Plan of Dissolution”) at the Company’s Annual Meeting of Stockholders held on June 5, 2025. In addition, The Company also announced the results of a recently completed additional cohort in its Phase 1 clinical trial of its oral wild-type KIT inhibitor development candidate, THB335, and that it is initiating the sale process of THB335 as part of the Plan of Dissolution.
Is It Worth Investing in Harmonic, Inc (NASDAQ: HLIT) Right Now?
Harmonic, Inc (NASDAQ: HLIT) has a price-to-earnings ratio of 20.54x that is above its average ratio. Additionally, the 36-month beta value for HLIT is 1.05. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 0 rating it as “sell.”
The public float for HLIT is 110.31M and currently, short sellers hold a 1.93% ratio of that float. The average trading volume of HLIT on June 13, 2025 was 941.68K shares.
HLIT’s Market Performance
The stock of Harmonic, Inc (HLIT) has seen a -0.64% decrease in the past week, with a -4.83% drop in the past month, and a -10.10% fall in the past quarter. The volatility ratio for the week is 2.62%, and the volatility levels for the past 30 days are at 1.84% for HLIT. The simple moving average for the past 20 days is -0.45% for HLIT’s stock, with a -19.91% simple moving average for the past 200 days.
Analysts’ Opinion of HLIT
Raymond James, on the other hand, stated in their research note that they expect to see HLIT reach a price target of $14, previously predicting the price at $17. The rating they have provided for HLIT stocks is “Outperform” according to the report published on October 29th, 2024.
HLIT Trading at 1.52% from the 50-Day Moving Average
After a stumble in the market that brought HLIT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -40.10% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HLIT starting from Whalen Daniel T, who purchase 2,000 shares at the price of $8.99 back on May 30 ’25. After this action, Whalen Daniel T now owns 11,840 shares of Harmonic, Inc, valued at $17,980 using the latest closing price.
Whalen Daniel T, the Director of Harmonic, Inc, purchase 1,000 shares at $9.99 during a trade that took place back on Feb 25 ’25, which means that Whalen Daniel T is holding 9,840 shares at $9,990 based on the most recent closing price.
Stock Fundamentals for HLIT
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.55 for the gross margin
The net margin for Harmonic, Inc stands at 0.08. The total capital return value is set at 0.17. Equity return is now at value 12.45, with 7.03 for asset returns.
Based on Harmonic, Inc (HLIT), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 0.88. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is 15.64.
Currently, EBITDA for the company is 77.4 million with net debt to EBITDA at -0.15. When we switch over and look at the enterprise to sales, we see a ratio of 1.5. The receivables turnover for the company is 7.0for trailing twelve months and the total asset turnover is 0.89. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.06.
Conclusion
In conclusion, Harmonic, Inc (HLIT) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
